Live feed
·
INSIDERFilingvia Quantisnow
Intra-Cellular Therapies Inc. logo

EVP, Chief Commercial Officer Neumann Mark converted options into 20,478 shares and covered exercise/tax liability with 8,688 shares, increasing direct ownership by 29% to 52,811 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Intra-Cellular Therapies Inc. logo
ITCI
Intra-Cellular Therapies Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for ITCI

Follow ITCI and get a push notification the moment its next story breaks.

Full ITCI profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.) and more on Quantisnow.